Cargando…

The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity

This investigation aims to assess whether the hepatocellular carcinoma cell line, HepG2, is an appropriate model to assess the role of poly (ADP-ribose) polymerase (PARP) during acute ethanol toxicosis. HepG2 cells were dosed with graded concentrations of ethanol, ranging from 100 mM to 800 mM, for...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, Jayme P, Mayo-Perez, A, Bourgeois, M, Johnson, G, Morris, S, Harbison, RD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366843/
https://www.ncbi.nlm.nih.gov/pubmed/25810958
http://dx.doi.org/10.4103/2229-5151.152300
_version_ 1782362432721649664
author Coyle, Jayme P
Mayo-Perez, A
Bourgeois, M
Johnson, G
Morris, S
Harbison, RD
author_facet Coyle, Jayme P
Mayo-Perez, A
Bourgeois, M
Johnson, G
Morris, S
Harbison, RD
author_sort Coyle, Jayme P
collection PubMed
description This investigation aims to assess whether the hepatocellular carcinoma cell line, HepG2, is an appropriate model to assess the role of poly (ADP-ribose) polymerase (PARP) during acute ethanol toxicosis. HepG2 cells were dosed with graded concentrations of ethanol, ranging from 100 mM to 800 mM, for 6 hours to assess PARP activity induction, while another parallel experiment examined cellular damage via medium aspartate aminotransferase activity and cellular viability via MTT reduction. Aspartate aminotransferase activity was significantly elevated at 600 mM ethanol (FOLD; P < 0.01), with further increases at the 800 mM dose (1.43 fold; P < 0.001), compared to controls. Cellular viability was not significantly decreased compared to controls among all dose groups. PARP activity measured in total cell lysates showed a significant decreasing trend with respect to ethanol dose, reaching statistical significance at the 100 mM dose group (P < 0.05). Paradoxically, exposure to 50 μM etoposide (Positive apoptosis-inducing control) did not demonstrate significant PARP activity ablation. When analyzing PARP activity observation temporally, a significant correlation (R(2) =0.5314) was observed between activity and assay sequence. Overall, a clear HepG2 insensitivity to ethanol was observed.
format Online
Article
Text
id pubmed-4366843
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43668432015-03-25 The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity Coyle, Jayme P Mayo-Perez, A Bourgeois, M Johnson, G Morris, S Harbison, RD Int J Crit Illn Inj Sci Original Article This investigation aims to assess whether the hepatocellular carcinoma cell line, HepG2, is an appropriate model to assess the role of poly (ADP-ribose) polymerase (PARP) during acute ethanol toxicosis. HepG2 cells were dosed with graded concentrations of ethanol, ranging from 100 mM to 800 mM, for 6 hours to assess PARP activity induction, while another parallel experiment examined cellular damage via medium aspartate aminotransferase activity and cellular viability via MTT reduction. Aspartate aminotransferase activity was significantly elevated at 600 mM ethanol (FOLD; P < 0.01), with further increases at the 800 mM dose (1.43 fold; P < 0.001), compared to controls. Cellular viability was not significantly decreased compared to controls among all dose groups. PARP activity measured in total cell lysates showed a significant decreasing trend with respect to ethanol dose, reaching statistical significance at the 100 mM dose group (P < 0.05). Paradoxically, exposure to 50 μM etoposide (Positive apoptosis-inducing control) did not demonstrate significant PARP activity ablation. When analyzing PARP activity observation temporally, a significant correlation (R(2) =0.5314) was observed between activity and assay sequence. Overall, a clear HepG2 insensitivity to ethanol was observed. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4366843/ /pubmed/25810958 http://dx.doi.org/10.4103/2229-5151.152300 Text en Copyright: © International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Coyle, Jayme P
Mayo-Perez, A
Bourgeois, M
Johnson, G
Morris, S
Harbison, RD
The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity
title The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity
title_full The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity
title_fullStr The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity
title_full_unstemmed The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity
title_short The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity
title_sort assessment of an in-vitro model for evaluating the role of parp in ethanol-mediated hepatotoxicity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366843/
https://www.ncbi.nlm.nih.gov/pubmed/25810958
http://dx.doi.org/10.4103/2229-5151.152300
work_keys_str_mv AT coylejaymep theassessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT mayopereza theassessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT bourgeoism theassessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT johnsong theassessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT morriss theassessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT harbisonrd theassessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT coylejaymep assessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT mayopereza assessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT bourgeoism assessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT johnsong assessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT morriss assessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity
AT harbisonrd assessmentofaninvitromodelforevaluatingtheroleofparpinethanolmediatedhepatotoxicity